(Q41914279)

14 October 2017

The disposition of amodiaquine in man after oral administration (English)

1 reference

14 October 2017

0 references

Winstanley P

1

1 reference

14 October 2017

Edwards G

series ordinal

2

1 reference

14 October 2017

Orme M

series ordinal

3

1 reference

14 October 2017

Breckenridge A

series ordinal

4

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

British Journal of Clinical Pharmacology

14 October 2017

1 reference

14 October 2017

23

1 reference

14 October 2017

1

1 reference

14 October 2017

1-7

1 reference

Disposition of chloroquine in man after single intravenous and oral doses

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Failure to detect amodiaquine in the blood after oral administration

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

The detection of amodiaquine in blood after oral administration

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Amodiaquine induced agranulocytosis and liver damage.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Agranulocytosis coincident with amodiaquine therapy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386133

Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods

16 June 2018

1 reference

12 December 2020

Fatal agranulocytosis during treatment with a amodiaquine

1 reference

12 December 2020

High-performance liquid chromatographic analysis of amodiaquine in human plasma

1 reference

12 December 2020

Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro

1 reference

12 December 2020

Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma

1 reference

12 December 2020

Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans

1 reference

12 December 2020

[Biotransformation of amiodaquine and prophylaxis of Plasmodium falciparum malaria]

1 reference

12 December 2020

10.1111/J.1365-2125.1987.TB03002.X

Identifiers

DOI

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

3814460

1 reference